Lidak other research news

LDAKA presented its new approach for viral vaccines at the First International Conference on Engineered Vaccines for Cancer and AIDS in San Francisco, showing that tiny silica beads coated with tumor-associated antigens can boost killer T cell responses to a tumor implanted into mice. Significant reduction or even elimination of murine tumors was documented with the LMI approach, the company reported. In addition, long-lasting tumor immunity has been detected in the mouse model. ...